Description
Added on the 16/03/2021 14:50:38 - Copyright : AFPTV - First images
The European Medicines Agency remains "firmly convinced" of the benefits of AstraZeneca's coronavirus vaccine despite several countries suspending its use over blood clot fears, the head of the regulator said on Tuesday.
The chief of the EU's medicines regulator says it is "firmly convinced" the benefits of AstraZeneca's jab outweigh potential risks, insisting there is no evidence linking the vaccine to blood clots after a host of nations suspended the shot over health fears.
Europe's medicines watchdog said on Tuesday the benefits of AstraZeneca's Covid-19 vaccine continue to outweigh the risks after several countries halted its use due to concerns about blood clots. EMA Executive Director Emer Cooke said there was no indication that the blood clot incidents, which he called "very rare" had been caused by the vaccine, but that experts were assessing that possibility.
The chief executive of Britain's independent medicines regulator, June Raine, announces that out of 79 cases of blood clots in people having received a first dose of the Oxford-AstraZeneca vaccine, 19 people have died, during a press conference over concerns about links between AstraZeneca's Covid-19 vaccine and blood clots. SOUNDBITE
UK medicines agency confirms seven deaths from rare blood clots from 18m people who received the AstraZeneca vaccine but says benefits still far outweigh risks.
Executive Director of the European Medicines Agency (EMA) Emer Cook says the AstraZeneca vaccine is "safe and effective" and not associated with a higher blood clot risk, after more than a dozen countries paused rollouts over health fears. IMAGES
|
Support : Technical 
- Content 
- Editors 
